Sante Cundari
About Sante Cundari
Sante Cundari is the Senior Director and Head of External Scientific Collaboration in Medical Affairs at Kite Pharma, specializing in cell therapy. He has extensive experience in medical affairs across various pharmaceutical companies, including Celgene and Mylan, and holds expertise in molecular biology and bio-organic synthesis.
Work at Kite Pharma
Currently, Sante Cundari serves as the Senior Director and Head of External Scientific Collaboration in Medical Affairs for Cell Therapy in the ACE Regions at Kite Pharma. He has held this position since 2020, working from Milan, Lombardy, Italy. In this role, he coordinates the launch and pre-launch activities of medical programs on various levels, including global and local. He is responsible for managing the budget and execution of external scientific and clinical collaborations, ensuring alignment with organizational goals.
Previous Experience in Medical Affairs
Sante Cundari has extensive experience in medical affairs, having worked at Celgene in various capacities from 2007 to 2019. His roles included Regional Medical Manager, Senior Director of Medical Affairs, and Executive Director of Global Medical Affairs. He also served as Head of Medical Affairs for Celgene from 2009 to 2014 in Milan, Italy. Additionally, he worked at Mylan as Senior Director of Biosimilar Oncology in Europe and at Portola Pharmaceuticals as Executive Director/General Manager for Italy.
Education and Expertise
Sante Cundari has a solid educational background in the sciences. He studied at the University of Calabria from 1990 to 1995 and attended Liceo Scientifico E. Fermi Cosenza from 1985 to 1990. He also pursued studies at University of Rome Tor Vergata from 2000 to 2001. His expertise lies in Molecular Biology and Bio-organic synthesis, which enhances his ability to interpret complex scientific data for development strategies.
Scientific Contributions and Collaborations
Sante Cundari actively participates in designing and evaluating clinical studies and scientific publications. He serves as a referee for the 'NEUROLOGY' Scientific Journal, which is the official journal of the American Academy of Neurology. He develops and maintains professional relationships with thought-leaders in Hematological Malignancies and Solid Tumors, contributing to advancements in the field.